Small Bovine Luteal Cells Research Articles

Localization of gene and protein expressions of tumor necrosis factor-α and tumor necrosis factor receptor types I and II in the bovine corpus luteum during the estrous cycle1

One of the many roles of tumor necrosis factor (TNF)-α is to control mammalian corpus luteum (CL) PG synthesis and apoptotic cell death. Here, the cellular localization of TNF-α and its type I (TNF-RI) and type II (TNF-RII) receptors in bovine luteal tissue were analyzed using in situ hybridization, immunohistochemistry, and quantitative real-time PCR. Transcripts for TNF-α were expressed in bovine CL throughout the estrous cycle, but were significantly more abundant (P < 0.01) at the regressed luteal stage than at the other stages. Localization of TNF-α transcripts and protein were observed in large and small bovine luteal cells, as well as in immune cells. Moreover, transcripts for TNF-RI and TNF-RII were expressed in bovine CL throughout the estrous cycle. The abundance of TNF-RII transcripts was greater (P < 0.01) at the regressed luteal stage than at the other stages, whereas TNF-RI transcript abundance did not significantly change. Expression of TNF-RI and TNF-RII transcripts and proteins were observed in both the large and small luteal cells, and the proteins were also expressed in the immune cells and vascular endothelial cells. These results suggest that TNF-α sources include immune cells, as well as large and small luteal cells, and that TNF-RI and TNF-RII are present in the luteal cells of the bovine CL.

Inter-relationships between endothelin and prostaglandin F2alpha in corpus luteum function.

In cattle and other species, the corpus luteum plays a central role in the regulation of cyclicity and maintenance of pregnancy. In the absence of fertilization and implantation, the corpus luteum undergoes functional and morphological regression or luteolysis. Luteal regression is initiated in domestic ruminants by surges of prostaglandin F2alpha (PGF2alpha) from the uterus. Despite intensive investigation, the mechanisms by which PGF2alpha causes luteal regression remain undetermined. Recent studies from several laboratories have demonstrated that endothelial cells and their product, endothelin 1, are required for the manifestation of the luteolytic effects of PGF2alpha. Experimental evidence strongly supports the concept that luteal endothelin 1 inhibits luteal steroidogenesis and mediates the effects of PGF2alpha. Endothelin 1 caused a dose-dependent reduction in both basal and luteinizing hormone-stimulated biosynthesis of progesterone and prostacyclin, and an increase in PGF2alpha by ovine and bovine luteal cells. Specific receptors for endothelin 1 were identified on large and small bovine luteal cells, and the addition of specific endothelin receptor antagonists abolished the inhibitory effects of endothelin 1. Luteal endothelin 1 content increased as the cyclic corpus luteum aged, and the highest concentrations were observed during luteolysis. The amount of mRNA encoding endothelin 1 was greatly increased during the period of luteolysis. Gene expression for endothelin 1 was increased, in a time-dependent manner, in corpora lutea collected from heifers and ewes after exogenous administration of PGF2alpha. In heifers, exogenous PGF2alpha resulted in increased luteal output of endothelin 1. In ewes, the luteolytic effects of PGF2alpha were mitigated by pretreatment with a specific endothelin receptor antagonist. Administration of endothelin 1 or a sub-luteolytic dose of PGF2alpha to ewes reduced concentrations of jugular venous progesterone but did not shorten luteal lifespan. However, a combination of endothelin 1 and PGF2alpha acted synergistically to bring about complete luteolysis and reduced lifespan of the corpus luteum. In summary, endothelin 1 appears to have a direct effect on luteal cells in cattle and sheep, and it plays an essential role in mediating the luteolytic effects of PGF2alpha.

Inter-relationships between endothelin and prostaglandin F2alpha in corpus luteum function

In cattle and other species, the corpus luteum plays a central role in the regulation of cyclicity and maintenance of pregnancy. In the absence of fertilization and implantation, the corpus luteum undergoes functional and morphological regression or luteolysis. Luteal regression is initiated in domestic ruminants by surges of prostaglandin F2alpha (PGF2alpha) from the uterus. Despite intensive investigation, the mechanisms by which PGF2alpha causes luteal regression remain undetermined. Recent studies from several laboratories have demonstrated that endothelial cells and their product, endothelin 1, are required for the manifestation of the luteolytic effects of PGF2alpha. Experimental evidence strongly supports the concept that luteal endothelin 1 inhibits luteal steroidogenesis and mediates the effects of PGF2alpha. Endothelin 1 caused a dose-dependent reduction in both basal and luteinizing hormone-stimulated biosynthesis of progesterone and prostacyclin, and an increase in PGF2alpha by ovine and bovine luteal cells. Specific receptors for endothelin 1 were identified on large and small bovine luteal cells, and the addition of specific endothelin receptor antagonists abolished the inhibitory effects of endothelin 1. Luteal endothelin 1 content increased as the cyclic corpus luteum aged, and the highest concentrations were observed during luteolysis. The amount of mRNA encoding endothelin 1 was greatly increased during the period of luteolysis. Gene expression for endothelin 1 was increased, in a time-dependent manner, in corpora lutea collected from heifers and ewes after exogenous administration of PGF2alpha. In heifers, exogenous PGF2alpha resulted in increased luteal output of endothelin 1. In ewes, the luteolytic effects of PGF2alpha were mitigated by pretreatment with a specific endothelin receptor antagonist. Administration of endothelin 1 or a sub-luteolytic dose of PGF2alpha to ewes reduced concentrations of jugular venous progesterone but did not shorten luteal lifespan. However, a combination of endothelin 1 and PGF2alpha acted synergistically to bring about complete luteolysis and reduced lifespan of the corpus luteum. In summary, endothelin 1 appears to have a direct effect on luteal cells in cattle and sheep, and it plays an essential role in mediating the luteolytic effects of PGF2alpha.

The possible involvement of LH/hCG induced mitochondrial proteins in the regulation of steroidogenesis in bovine luteal cells

In previous studies we described the synthesis of three mitochondrial proteins (A, B and C) in response to acute in vitro stimulation by lutropin of small bovine luteal cells. Protein A had a molecular weight of 28 kDa and an isolectric point (pI) of 6.7. Proteins B and C had a molecular mass of 27 kDa and pI of 6.2 and 6.4, respectively. The appearance of these proteins was prevented by 100 μM cycloheximide. In the present study, we have shown that the time course of synthesis of protein A and its hCG dose-response closely parallel the increase in progesterone production. The induction by hCG of protein A was already observed after a 5 min incubation. Pulse chase experiments by addition of excess unlabelled methionine after prelabelling with [ 35S]methionine indicated that its half-life was approximately 15–20 min. Study of 32P labelled phosphate incorporation into individual proteins and treatment by alkaline phosphatase of [ 35S]methionine-labelled proteins demonstrated that none of the three proteins A, B or C was a phosphoprotein. Localization of protein A in mitochondria, at the site of the rate limiting step in steroidogenesis, and the high degree of correlation between its 35S labelling and progesterone production argue in favour of its involvement in the acute regulation of steroidogenesis.

Contact-associated interactions between large and small bovine luteal cells during the estrous cycle

This experiment was designed to study the effects of cell-to-cell contact, arachidonic acid (10 μM; AA), oxytocin (10 μM), and luteinizing hormone (5 ng; LH) on bovine luteal cell function. Corpora lutea collected from Holstein cows between Days 10 and 12 (n = 4; midluteal stage) or 17 and 18 (n = 4; late-luteal stage) of the estrous cycle (Day 0 = estrus) were dispersed, and small and large cells were separated by unit gravity sedimentation and flow cytometry. Large and small luteal cells were either incubated together, allowing intercellular contact, or separately, without intercellular contact, with culture well inserts. Cells were incubated in a modified Ham's F-12- N-hydroxyethylpiperazine- N′-2-ethanesulfonic acid medium. After an 18-hr preincubation period, treatments were introduced and cells were incubated for 240 hr. Media samples were collected and treatments were replaced at 48-hr intervals. Incubations were maintained at 37° C in 5% CO 2 in humidified air. Overall, progesterone secretion decreased with increased incubation time (P < 0.0001), regardless of treatment, stage of the cycle, or cell arrangement. During the 18-hr pre-treatment period, large and small luteal cells with contact secreted more progesterone than did luteal cells without contact during both the mid- (P < 0.0001) and late-luteal stages (P < 0.06) of the estrous cycle. After treatments were initiated, both mid- and late-stage luteal cells treated with LH secreted more (P < 0.0001) progesterone than occurred with any other treatment; oxytocin, AA, and control treatments were similar. A significant treatment × incubation time × intercellular contact interaction showed that: 1) after 48 hr of treatment, luteal cells without contact in the control and AA treatment groups secreted more progesterone (P < 0.01) than did luteal cells with contact; no other differences were found between the two cell arrangements within these treatment groups; 2) progesterone secretion by luteal cells with contact after treatment with LH for 48 hr was greater (P < 0.001) than that by luteal cells without contact; no other differences were found between the two cell arrangements within this treatment group; 3) no differences were found between the two cell arrangements throughout the incubation treatment period in the oxytocin-treated cells. These data suggest that large and small bovine luteal cells interact to regulate progesterone production during mid- and late-luteal stages of the estrous cycle and that this interaction is modified by endogenous compounds present at the level of the corpus luteum.

Interactions between large and small luteal cells collected during the mid- or late-luteal stages of the bovine oestrous cycle.

The effects of contact between large and small bovine luteal cells together with those of luteinizing hormone (LH) or arachidonic acid (AA) on progesterone production during the oestrous cycle were investigated. Corpora lutea were collected during the mid-luteal stage (Days 10-12; n = 4) and late-luteal stage (Days 17-18; n = 4) of the oestrous cycle. Large and small luteal cells were dispersed and separated and then incubated together or separately. Mid-luteal stage cells were treated with LH (0 or 5 ng) whereas late-luteal stage cells were treated with LH (0 or 5 ng) or AA (0 or 10 microM). Culture medium was collected and replaced 1, 3 and 6 h after starting treatments. Progesterone production decreased (P < 0.0001) with increased incubation time irrespective of cell arrangement, the stage of the oestrous cycle or treatment. During the 18 h before treatment, cells in the contact arrangement produced more progesterone (P < 0.003) than cells without contact in both mid- and late-luteal stages of the oestrous cycle; progesterone production within cell arrangements between prospective treatment groups was similar. After initiating treatments, mid-luteal stage cells in the control group without contact produced more progesterone (P < 0.01) than cells with contact. Mid-luteal stage cells treated with LH produced more (P < 0.0001) than control cells; progesterone production between cell arrangements within the LH treatment group was similar. In the late-luteal stage cells, both LH and AA increased (P < 0.01) progesterone production by comparison with control cells; LH and AA treatment groups produced similar results.(ABSTRACT TRUNCATED AT 250 WORDS)

Interactions between large and small bovine luteal cells in a sequential perifusion co-culture system.

The objectives of this experiment were to study large and small luteal cell interactions and examine the effect of arachidonic acid (AA) on progesterone production by separated bovine luteal cells. Corpora lutea collected from Holstein cows (n = 5) on d 12 of the estrous cycle were dispersed, and small (SLC) and large (LLC) luteal cells were separated by unit gravity sedimentation and flow cytometry. Cells were incubated at 37 degrees C in separate perifusion chambers with a modified Ham's F-12-HEPES medium and aerated with 95% O2:5% CO2. The flow rate of medium was 100 microL/min, and fractions were collected at 30-min intervals for 4 h. Luteal cells were arranged in tandem so that medium from the first cell type would pass through the chamber containing the second cell type. Luteal cells were arranged so that medium flowed from 1) SLC to SLC, 2) LLC to LLC, 3) SLC to LLC, 4) LLC to SLC, 5) SLC to LLC, 6) LLC to SLC; medium for arrangements 5 and 6 contained 10 microM AA. Cells in arrangements 5 and 6 were perifused for 30 min before AA was added. Progesterone was measured with an enzymeimmunoassay. The LLC to LLC arrangement had a greater (P < .05) average progesterone secretion rate than all other cell arrangements, and the SLC to SLC arrangement had the least progesterone secretion rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Conversion of 5(10)-oestrene-3β,17β-diol to 19-nor-4-ene-3-ketosteroids by luteal cells in vitro: possible involvement of the 3β-hydroxysteroid dehydrogenase/isomerase

We have previously suggested that in porcine granulosa cells, a putative intermediate, 5(10)-oestrene-3,17-dione is involved in 4-oestrene-3,17-dione (19-norandrostenedione; 19-norA) and 4-oestren-17 beta-ol-3-one (19-nortestosterone: 19-norT) formation from C19 aromatizable androgens. In this study, luteal cells prepared from porcine, bovine and rat corpora lutea by centrifugal elutriation were used as a source of 3 beta-hydroxysteroid dehydrogenase/isomerase in order to investigate the role of this enzyme in the biosynthesis of 19-norsteroids. Small porcine luteal cells made mainly 19-norT and large porcine luteal cells 19-norA from 5(10)-oestrene-3 beta,17 beta-diol, the reduced product of the putative intermediate 5(10)-oestrene-3,17-dione. However, neither small nor large cells metabolized androstenedione to 19-norsteroids. Serum and serum plus LH significantly stimulated formation of both 19-norA and 19-norT from 5(10)-oestrene-3 beta,17 beta-diol, compared with controls. Inhibitors of the 3 beta-hydroxysteroid dehydrogenase/isomerase (trilostane and cyanoketone) significantly reduced formation of 19-norT in small porcine luteal cells and 19-norA in large porcine luteal cells, although they were effective at different concentrations in each cell type. In parallel incubations, formation of [4-14C]androstenedione from added [4-14C]dehydroepiandrosterone was also inhibited by cyanoketone in both small and large porcine luteal cells in a dose-dependent manner; however, trilostane (up to 100 mumol/l) did not inhibit androstenedione formation in large porcine luteal cells. In addition, the decrease in progesterone synthesis induced by trilostane and cyanoketone (100 mumol/l each) was accompanied by a parallel accumulation of pregnenolone in both cell types. These results suggest that 3 beta-hydroxysteroid dehydrogenase/isomerase, or a closely related enzyme, present in small and large porcine luteal cells can convert added 5(10)-3 beta-hydroxysteroids into 19-nor-4(5)-3-ketosteroids in vitro. In the porcine ovarian follicle, therefore, formation of 19-norA from androstenedione can be envisaged as a two-step enzymatic process: 19-demethylation of androstenedione to produce the putative intermediate 5(10)-oestrene-3,17-dione, and subsequent isomerization to 19-norA. In contrast to granulosa cells, porcine luteal cells synthesized 19-norA or 19-norT only when provided with the appropriate substrate. Unfractionated rat luteal cells also metabolized 5(10)-oestrene-3 beta,17 beta-diol to a mixture of 19-norA and 19-norT; conversion was inhibited by trilostane. In addition, small bovine luteal cells synthesized mainly 19-norT and formation was also inhibited by trilostane and cyanoketone.(ABSTRACT TRUNCATED AT 400 WORDS)

Inhibition of progesterone synthesis and cAMP accumulation in small bovine luteal cells by a low molecular weight component of bovine follicular fluid

Follicular fluid from large follicles of cows was extracted with charcoal and filtered through an Amicon XM-50 membrane. The XM-50 filtrate was further fractionated on a column of Fractogel TSK HW-40 (s) using Krebs-Ringer-phosphate buffer (1/100th dilution), pH 7.2, as an eluant. Two fractions (1 and 2) were obtained. Inhibition of progesterone secretion by small luteal cells was associated with the XM-50 filtrate and Fraction 2. Whole follicular fluid, the XM-50 retentate and Fraction 1 had no significant inhibitory activity. Fraction 2, which contained about 1/100,000th of the original follicular fluid proteins, inhibited the LH- or (Bu)2cAMP-induced progesterone production during a 2-h incubation. This inhibition was dose-dependent. Fraction 2 also inhibited LH-induced cAMP accumulation, but did not affect the conversion of pregnenolone to progesterone or the basal progesterone production. The molecular weight of the inhibitory factor was estimated to be less than 10,000 and its ability to inhibit steroidogenesis was lost after digestion with protease but retained after heating for 60 min at 75 degrees C. These results demonstrate that bovine follicular fluid contains a heat-stable factor likely to be a polypeptide and which suppresses the steroidogenic response of small luteal cells to LH. The action of this inhibitory factor could involve both an inhibition of the LH-induced synthesis of cAMP and an inhibition of the action of cAMP.

Involvement of the phospholipase C second messenger system in the regulation of steroidogenesis in small bovine luteal cells

We have previously suggested that the interaction between luteinizing hormone (LH) and its receptor, in addition to stimulating adenylate cyclase, is able to trigger a negative regulatory signal at a step beyond cAMP synthesis (Benhaim et al. (1987) FEES Lett. 223, 321–326). The present study was conducted to determine whether the phospholipase C system is involved in this phenomenon. Small bovine luteal cells from pregnant cows were incubated with phospholipase C, A23187, an ionophore of calcium and/or phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C (PKC), in the presence or absence of bovine luteinizing hormone or dibutyryl cyclic AMP (dbcAMP). A23187 associated with PMA was able to mimic the stimulatory effect of phospholipase C on basal progesterone production, whereas neither A23187 nor PMA alone had any effect. In the presence of high doses of LH, phospholipase C inhibited progesterone and cAMP production in a dose-dependent manner. A23187 and PMA were able to mimic the inhibition of progesterone synthesis but stimulated LH-induced cAMP accumulation. When cells were stimulated by high doses of dbcAMP, phospholipase C and A23187 but not PMA inhibited progesterone synthesis. These observations suggest that (1) phospholipase C can mimic the post-cAMP negative regulatory signal induced in vitro by high doses of LH, in the presence of an activation of PKC; (2) phospholipase C is also able to mimic in vitro the luteolytic properties of prostaglandin F 2α that we previously described (Benhaim et al. (1987) Prostaglandins 33, 227–239); and (3) under basal conditions or in the presence of low doses of LH, the phospholipase C system slightly stimulates steroidogenesis.

Acute effects of prostaglandin F 2α on inositol phospholipid hydrolysis in the large and small cells of the bovine corpus luteum

The present studies were conducted to determine whether the large or small bovine luteal cell was the site for the stimulatory effect of prostaglandin F 2α (PGF) on phospholipase C-catalyzed inositol phospholipid hydrolysis. Corpora lutea were removed from heifers during the luteal phase of the normal estrous cycle. Small luteal cells were isolated by unit-gravity sedimentation and large luteal cells were isolated by flow cytometry using a Becton Dickinson FACS 440 cell sorter. PGF provoked rapid (5–30 s) and sustained (up to 30 min) increases in the levels of inositol mono-, bis-, and trisphosphates (IP, IP 2, IP 3, respectively) in small luteal cells. IP 3 was formed more rapidly than IP 2 or IP following PGF treatment. The PGF-stimulated increase in IP 3 was accompanied by a transient reduction in the levels of 3H-labeled phosphatidylinositol 4,5-bisphosphate. LiCl (10 mM) enhanced inositol phosphate accumulation in response to PGF. Maximal increases in inositol phosphate accumulation were observed with 1–10 μM PGF and half-maximal increases were observed with 60 nM PGF. PGF (1–10 μM) had no effect on cAMP levels but stimulated small increases in progesterone accumulation in 30 min incubations of small luteal cells. PGF also increased the accumulation of inositol phosphates in large luteal cells. The increases were apparent within 5 min of incubation (the earliest time examined) and further increases were observed in incubations lasting 30 min. PGF had no significant effect on cAMP or progesterone in 30 min incubations of large cells. These findings demonstrate that PGF stimulates phospholipase C activity in both large and small bovine luteal cells and provide further evidence for the involvement of calcium and protein kinase C in the action of PGF.

Effects of phorbol esters on steroidogenesis in small bovine luteal cells

The possible influence of an activator of protein kinase C, the tumor-promoting phorbol ester, PMA (phorbol-12-myristate-13-acetate), upon small bovine luteal cell steroidogenesis was investigated in vitro. PMA had no significant effect on basal and dibutyryl cyclic AMP (dbcAMP)-stimulated progesterone production but markedly modulated the LH-stimulated progesterone and cAMP productions. PMA potentiated the LH-stimulated cAMP accumulation whatever the dose of LH used. It also potentiated the LH-induced progesterone production in the presence of low doses of LH. Paradoxically, in the presence of maximal or submaximal effective doses of LH, PMA exerted a time- and dose-dependent inhibition of progesterone synthesis. Diacylglycerol was able to mimic the effects of PMA on LH-induced steroidogenesis. These observations suggest that the Ca 2+- and phospholipid-dependent protein kinase C can modulate the regulation by LH of small bovine luteal cell steroidogenesis at a step before the synthesis of cAMP. They also suggest that the interaction between LH and its receptor is able to trigger a negative regulatory signal which would be only expressed for high doses of LH and in the presence of an activator of PKC.

In vitro action of PG F 2σ on progesterone and cAMP synthesis in small bovine letual cells

• The action of prostaglandin F 2σ (PG F 2σ) on incubated small bovine luteal cells in the presence or in the absence of bovine luteinizing hormone (LH) or dibutyryl cyclic adenosine monophosphate (db cAMP) was investigated. • In the absence of LH and db cAMP, PG F 2σ stimulated progesterone synthesis at concentrations of 10 ng/ml and 100 ng/ml but had no effects at concentrations below 1 ng/ml. PG F 2σ partially inhibited the LH or db cAMP stimulated progesterone synthesis. This inhibition was maximal for PG F 2σ concentrations around 100 pg/ml whereas distinctly higher or lower concentrations were without effect. At the concentration of 100 pg/ml, PG F 2σ partially inhibited the LH induced cAMP accumulation. • These results demonstrate an “in vitro” action of PG F 2σ on bovine luteal cells. They indicate that the luteolytic action of PG F 2σ in the bovine species could involve, as already suggested for the rat, both an inhibition of the LH induced synthesis of cAMP and on inhibition of the action of cAMP.

Estradiol-17β inhibition of lutropin and dibutyryl cyclic amp induced steroidogenesis in intact bovine luteal cells. absence of effect on induced protein phosphorylations

Estradiol-17β is known to inhibit in a dose dependent manner the lutropin-induced stimulation of progesterone synthesis in luteal cells without affecting the intracellular cyclic AMP increase produced by the hormone. The hypothesis that this inhibitory action could involve an inhibition of the cyclic AMP dependent phosphorylation of cytosolic proteins was investigated by using incubations of selected small bovine luteal cells. Doses of 10 and 100 μ/ml ofestradiol-17β inhibited respectively 60 and 90% of the progesterone synthesis induced by lutropin as well as by dibutyryl cyclic AMP in small bovine luteal cells. At the concentrations of 10 and 100 μ/ml, estradiol-17β was unable to affect the cyclic AMP dependent protein kinase activation induced by lutropin. At the concentration of 10 μg/ml the steroid was without effect on the lutropin or dibutyryl cyclic AMP induced protein phosphorylations. However 100 μ/ml of estradiol-17β seemed to produce a slight inhibition of the induced protein phosphorylations.

Aromatization of testosterone in large and small bovine luteal cells. Conflicting results between radioimmunoassay and cocrystallization data

The ability of isolated large or small bovine luteal cells to synthesize estradiol-17β was tested by incubations in the absence or in the presence of exogenous testosterone. Using a specific radioimmunoassay, no synthesis of estradiol-17β could be detected in the small or large luteal cells after incubation in the absence of testosterone. However, after incubation in the presence of exogenous unlabelled testosterone, radioimmunoassay data suggested the existence in the large but not the small luteal cells of synthesis of estradiol-17β. However, the results obtained by measuring the conversion of 3H-testosterone to 3H-estradiol-17β by cocrystallization with unlabelled estradiol-17β failed to confirm the presence of aromatase in the large cells. These data indicate that aromatization in large and small bovine luteal cells is probably negligible. Moreover, they cast serious doubt on studies of aromatization in luteal tissue based on radioimmunoassay data only.